$MHUA
Meihua International Medical Technologies Co., Ltd. Stock $mhua

$mhua Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000121390024035784 Filed on April 24, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$97.10M	$97.10M	$103.3M
YoY Change	-6.05%	-6.05%
Cost Of Revenue	$63.90M	$63.90M	$65.25M
YoY Change	-2.06%	-2.06%
Gross Profit	$33.20M	$33.20M	$38.10M
YoY Change	-12.86%	-12.86%
Gross Profit Margin	34.19%	34.19%	36.86%
Selling, General & Admin	$15.59M	$13.84M	$19.45M
YoY Change	-19.85%	-29.33%
% of Gross Profit	46.96%	41.68%	51.06%
Research & Development	$2.743M	$2.753M	$2.955M
YoY Change	-7.15%	-7.07%
% of Gross Profit	8.26%	8.29%	7.76%
Depreciation & Amortization	$180.4K	$408.2K	$134.8K
YoY Change	33.81%	-24.58%
% of Gross Profit	0.54%	1.23%	0.35%
Operating Expenses	$18.52M	$18.52M	$27.30M
YoY Change	-32.14%	-32.14%
Operating Profit	$14.67M	$14.67M	$10.80M
YoY Change	35.85%	35.85%
Interest Expense	$469.2K	$469.2K	$142.5K
YoY Change	229.3%	229.3%
% of Operating Profit	3.2%	3.2%	1.32%
Other Income/Expense, Net	-$95.38K	$373.8K	-$53.21K
YoY Change	79.25%	-518.7%
Pretax Income	$15.05M	$15.05M	$10.89M
YoY Change	38.17%	38.17%
Income Tax	$3.458M	$3.458M	$4.714M
% Of Pretax Income	22.98%	22.98%	43.28%
Net Earnings	$11.63M	$11.63M	$6.243M
YoY Change	86.22%	86.22%
Net Earnings / Revenue	11.97%	11.97%	6.04%
Basic Earnings Per Share		$0.49
Diluted Earnings Per Share	$0.49	$0.49	$0.27
COMMON SHARES
Basic Shares Outstanding	23.94M shares	23.94M shares	23.94M shares
Diluted Shares Outstanding		23.94M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.93M	$16.93M	$26.74M
YoY Change	-36.69%	-36.69%
Cash & Equivalents	$16.93M		$26.74M
Short-Term Investments
Other Short-Term Assets	$14.21M	$14.21M	$16.43M
YoY Change	-13.49%	-13.49%
Inventory	$1.617M	$1.617M	$1.122M
Prepaid Expenses
Receivables	$78.57M	$79.03M	$68.95M
Other Receivables	$20.45M	$20.45M	$239.1K
Total Short-Term Assets	$132.2M	$132.2M	$135.3M
YoY Change	-2.28%	-2.28%	39.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.831M	$8.838M	$8.758M
YoY Change	0.83%	0.91%	17.12%
Goodwill
YoY Change
Intangibles	$3.916M		$497.6K
YoY Change	686.96%		-11.46%
Long-Term Investments	$6.132M	$6.132M	$6.670M
YoY Change	-8.06%	-8.06%
Other Assets	$11.27M	$20.79M	$12.33M
YoY Change	-8.64%	68.59%
Total Long-Term Assets	$39.68M	$39.68M	$28.26M
YoY Change	40.41%	40.41%	-28.61%
TOTAL ASSETS
Total Short-Term Assets	$132.2M	$132.2M	$135.3M
Total Long-Term Assets	$39.68M	$39.68M	$28.26M
Total Assets	$171.9M	$171.9M	$163.6M
YoY Change	5.1%	5.1%	19.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.82M	$15.82M	$16.10M
YoY Change	-1.7%	-1.7%	-23.28%
Accrued Expenses	$1.199M	$1.199M	$1.238M
YoY Change	-3.16%	-3.16%
Deferred Revenue
YoY Change
Short-Term Debt	$7.324M	$7.324M	$6.089M
YoY Change	20.27%	20.27%	17.59%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$25.07M	$25.07M	$24.17M
YoY Change	3.72%	3.72%	-16.9%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$724.9K
YoY Change		-100.0%
Other Long-Term Liabilities	$4.590K	$4.590K
YoY Change
Total Long-Term Liabilities	$0.00	$4.590K	$724.9K
YoY Change	-100.0%	-99.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.07M	$25.07M	$24.17M
Total Long-Term Liabilities	$0.00	$4.590K	$724.9K
Total Liabilities	$25.08M	$25.58M	$24.90M
YoY Change	0.72%	0.51%	-14.41%
SHAREHOLDERS EQUITY
Retained Earnings	$94.64M		$83.33M
YoY Change	13.57%		7.42%
Common Stock	$11.97K		$11.97K
YoY Change	0.0%		19.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$146.3M	$146.3M	$138.1M
YoY Change
Total Liabilities & Shareholders Equity	$171.9M	$171.9M	$163.6M
YoY Change	5.1%	5.1%	19.52%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	$11.63M	$11.63M	$6.243M
YoY Change	86.22%	86.22%
Depreciation, Depletion And Amortization	$180.4K	$408.2K	$134.8K
YoY Change	33.81%	-24.58%
Cash From Operating Activities	$7.696M	$2.276M
YoY Change		-124.84%
INVESTING ACTIVITIES
Capital Expenditures	$106.6K	$1.183M
YoY Change		-56.18%
Acquisitions
YoY Change
Other Investing Activities	-$8.492M	-$7.772M
YoY Change		31.25%
Cash From Investing Activities	-$8.589M	-$12.46M
YoY Change		44.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-13.87K	$706.1K
YoY Change		-98.1%
NET CHANGE
Cash From Operating Activities	7.696M	$2.276M
Cash From Investing Activities	-8.589M	-$12.46M
Cash From Financing Activities	-13.87K	$706.1K
Net Change In Cash	-906.8K	-$9.810M
YoY Change		-152.78%
FREE CASH FLOW
Cash From Operating Activities	$7.696M	$2.276M
Capital Expenditures	$106.6K	$1.183M
Free Cash Flow	$7.589M	$1.093M
YoY Change		-109.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41291
CY2023	dei	Entity Registrant Name EntityRegistrantName	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	88 Tongda Road
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Touqiao Town
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Guangling District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Yangzhou
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	225000
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Security12b Title Security12bTitle	Ordinary Share, $0.0005 par value
CY2023	dei	Trading Symbol TradingSymbol	MHUA
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23940000	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	6651
CY2023	dei	Auditor Name AuditorName	Kreit & Chiu CPA LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16926878	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26736700	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	20431900	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	22085846	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	78570956	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	68945792	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1617225	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1122038	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14212606	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16428779	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	132237053	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	135319155	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8830968	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8758047	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3915917	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	497600	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	6131941	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163577579	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	97098915	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	6669655	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11267764	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12333122	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7087	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	369483	usd
CY2023Q4	us-gaap	Assets Assets	171915272	usd
CY2022Q4	us-gaap	Assets Assets	163577579	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	7324047	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	6089428	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15822029	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16096165	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1082131	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1131276	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	842156	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	856698	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2495	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25072858	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24173567	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	724932	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4592	usd
CY2023Q4	us-gaap	Liabilities Liabilities	25077450	usd
CY2022Q4	us-gaap	Liabilities Liabilities	24898499	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23940000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23940000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20000000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	11970	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11970	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0005
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0005
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42967006	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42967006	usd
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	15985627	usd
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	15665860	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	94635889	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	83330239	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7268652	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3852138	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	146331840	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	138122937	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	505982	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	556143	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	146837822	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	138679080	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	171915272	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	103346341	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	104037710	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	63900597	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	65247864	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	64232469	usd
CY2023	us-gaap	Gross Profit GrossProfit	33198318	usd
CY2022	us-gaap	Gross Profit GrossProfit	38098477	usd
CY2021	us-gaap	Gross Profit GrossProfit	39805241	usd
CY2023	us-gaap	Selling Expense SellingExpense	7295460	usd
CY2022	us-gaap	Selling Expense SellingExpense	7109524	usd
CY2021	us-gaap	Selling Expense SellingExpense	6457801	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6540944	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12468551	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4361472	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2753315	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2962904	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2725014	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4755536	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1933661	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	18523380	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	27296515	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	13544287	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	14674938	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	10801962	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	26260954	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-250781	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-194667	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-180744	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	873439	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	63725	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	23855	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-153440	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	273432	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	174413	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-95382	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-53205	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-50437	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	373836	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	89285	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-32913	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15048774	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10891247	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26228041	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3457733	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4713543	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5278462	usd
CY2023	us-gaap	Profit Loss ProfitLoss	11591041	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6177704	usd
CY2021	us-gaap	Profit Loss ProfitLoss	20949579	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-34376	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-65265	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	11625417	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6242969	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	20949579	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3432299	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9155028	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2083243	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	8158742	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2977324	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	23032822	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-50161	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-79167	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8208903	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2898157	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23032822	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23940000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23411068	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20000000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	84735780	usd
CY2021	us-gaap	Profit Loss ProfitLoss	20949579	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2083243	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	107768602	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	33252492	usd
CY2022	us-gaap	Stockholders Equity Other StockholdersEquityOther	635310	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6177704	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-9155028	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	138679080	usd
CY2023	us-gaap	Profit Loss ProfitLoss	11591041	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-3432299	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	146837822	usd
CY2023	us-gaap	Profit Loss ProfitLoss	11591041	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6177704	usd
CY2021	us-gaap	Profit Loss ProfitLoss	20949579	usd
CY2023	us-gaap	Depreciation Depreciation	408233	usd
CY2022	us-gaap	Depreciation Depreciation	541265	usd
CY2021	us-gaap	Depreciation Depreciation	595522	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62149	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22196	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26951	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-102319	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-25023	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-15281	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4755536	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1933661	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-370475	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized After Tax ForeignCurrencyTransactionGainLossRealizedAfterTax	-153440	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized After Tax ForeignCurrencyTransactionGainLossRealizedAfterTax	273432	usd
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	4832	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	611	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1026148	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	4284515	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	6533717	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13558315	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7121889	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20065904	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	457585	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	528635	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-35027	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-105121	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1760865	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4932145	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	861799	usd
CY2023	us-gaap	Increase Decrease Due From Other Related Parties IncreaseDecreaseDueFromOtherRelatedParties	21184	usd
CY2021	us-gaap	Increase Decrease Due From Other Related Parties IncreaseDecreaseDueFromOtherRelatedParties	-396583	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	185902	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3371275	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4908971	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-16893	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-812412	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	288659	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	9911	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	75879	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	120090	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-611	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2275750	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9163038	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54663	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1182699	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2698729	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	850231	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3503883	usd
CY2022	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	5944709	usd
CY2023	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	353062	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	348321	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	23146	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16414	usd
CY2023	mhua	Collection Of Longterm Deposits For Buildings CollectionOfLongtermDepositsForBuildings	706125	usd
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	9179624	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12458698	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8620292	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-833817	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	6637574	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	7579135	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	6510820	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	743052	usd
CY2022	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	635310	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	34529644	usd
CY2023	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	5931449	usd
CY2022	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	6241641	usd
CY2021	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	4650586	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	706125	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37245500	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1860234	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-332999	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-874746	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9812	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9809822	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18587424	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	961942	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26736700	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8149276	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7187334	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16926878	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26736700	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8149276	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	250781	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	194667	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	180744	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	3583143	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	5703288	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	5042816	usd
CY2022	mhua	Shareholder Contribution Through Deferred Cost ShareholderContributionThroughDeferredCost	1277152	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7697	usd
CY2015Q4	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	53911815	hkd
CY2015Q4	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	6911771	usd
CY2021Q4	mhua	Subsidiary Percentage SubsidiaryPercentage	0.55	pure
CY2023Q4	mhua	Subsidiary Percentage SubsidiaryPercentage	0.51	pure
CY2023	mhua	Description Of Yongjun Liu Surrendered Shares DescriptionOfYongjunLiuSurrenderedShares	Yongjun Liu surrendered 49,999 shares to the Company for cancellation. The Company subdivided each existing share with a par value of $1.00 into 2,000 shares with a par value of $0.0005 par value and created a new class of preferred shares. Upon completion of the share capital changes, the Company’s share capital includes 80,000,000 ordinary shares with a par value of $0.0005 per share and 20,000,000 preferred shares with a par value of $0.0005 per share.
CY2023	mhua	Description Of Corporate Reorganization DescriptionOfCorporateReorganization	the Company engaged in a corporate reorganization to combine the controlled entities (now referred to as the subsidiaries) into one legal corporation (the Company). The specific transactions related to this reorganization are outlined below. The Company entered into a share exchange agreement with Kang Fu to issue an aggregate of 15,933,000 ordinary shares to Yongjun Liu and Yin Liu in exchange for 100% ownership of Kang Fu, and allotted 2,640,000 ordinary shares at $0.0005 par value to three BVI companies held by founders of the Company for no consideration. On December 22, 2020, Guanghui was incorporated for the purpose of foreign exchange registration under the laws of the People’s Republic of China as there was no substantive business of Guanghui. The shares of Guanghui are owned by 13 natural persons (the “Guanghui Shareholders”) and on May 10, 2021, all of the Guanghui Shareholders agreed to transfer all their shares held in Guanghui to Huadong (an indirect subsidiary of the Company) for no consideration.
CY2020Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1425000	shares
CY2020Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1616971	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and related notes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The most significant estimates and judgments include allowance for credit losses, the valuation of inventory, useful life of property, plant and equipment and income taxes related to realization of deferred tax assets and uncertain tax position. Actual amounts could differ from those estimates.</p>
CY2023	mhua	Period Ended Spot PeriodEndedSpot	1	usd
CY2023	mhua	Period Ended Spots PeriodEndedSpots	7.0999
CY2022	mhua	Period Ended Spot PeriodEndedSpot	1	usd
CY2022	mhua	Period Ended Spots PeriodEndedSpots	6.8972
CY2021	mhua	Period Ended Spot PeriodEndedSpot	1	usd
CY2021	mhua	Period Ended Spots PeriodEndedSpots	6.3726
CY2023	mhua	Period Average PeriodAverage	1	usd
CY2023	mhua	Period Averages PeriodAverages	7.0809
CY2022	mhua	Period Average PeriodAverage	1	usd
CY2022	mhua	Period Averages PeriodAverages	6.729
CY2021	mhua	Period Average PeriodAverage	1	usd
CY2021	mhua	Period Averages PeriodAverages	6.4508
CY2023	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	7.8	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Certain Risks and Concentration</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and receivables. As of December 31, 2023 and 2022 substantially all the Company’s cash was held in major financial institutions located in Hong Kong and mainland China, which institutions management considers to be of high credit quality.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2023, one customer accounted for approximately 16.84% of the Company’s total revenues. For the year ended December 31, 2022, two customers accounted for approximately 27.63% and 10.97% of the Company’s total revenues, respectively. For the year ended December 31, 2021, two customers accounted for approximately 21.91% and 11.26% of the Company’s total revenues, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2023, one customer accounted for approximately 15.63% of the Company’s accounts receivable. As of December 31, 2022, two customers accounted for approximately 27.73% and 13.14% of the Company’s accounts receivable, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2023, one supplier accounted for approximately 14.46% of the Company’s total purchases. For the year ended December 31, 2022, one supplier accounted for approximately 11.93% of the Company’s total purchases. There was no supplier that individually represented greater than 10% of the total purchase of the Group for the year ended December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023	mhua	Revenues Percentage RevenuesPercentage	0.1446	pure
CY2022	mhua	Revenues Percentage RevenuesPercentage	0.1193	pure
CY2021	mhua	Revenues Percentage RevenuesPercentage	0.10	pure
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1933661	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14212606	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16428779	usd
CY2023	mhua	Current Vat Rate Percentage CurrentVatRatePercentage	0.13	pure
CY2023Q1	mhua	Equitys Interest Percentage EquitysInterestPercentage	0.05	pure
CY2023Q1	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	353062	usd
CY2023Q1	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	2500000	cny
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	4832	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	290	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	97098915	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	103346341	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	104037710	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	97098915	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	103346341	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	104037710	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	8096	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	95432	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	21498	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2753315	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2962904	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2725014	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	97098915	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	103346341	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	104037710	usd
CY2023	mhua	Others Products OthersProducts	6972359	usd
CY2022	mhua	Others Products OthersProducts	10849537	usd
CY2021	mhua	Others Products OthersProducts	9065588	usd
CY2023	mhua	Total Products TotalProducts	97098915	usd
CY2022	mhua	Total Products TotalProducts	103346341	usd
CY2021	mhua	Total Products TotalProducts	104037710	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	80955803	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	68945792	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1928486	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	79027317	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	68945792	usd
CY2023Q4	mhua	Less Accounts Receivable Net Related Parties LessAccountsReceivableNetRelatedParties	-456361	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	78570956	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	68945792	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1933661	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1933661	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Loss Foreign Currency Translation FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation	5175	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1928486	usd
CY2023Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	127901	usd
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	239148	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	250410	usd
CY2023Q4	mhua	Prepaid For Land Use Right PrepaidForLandUseRight	14084705	usd
CY2022Q4	mhua	Prepaid For Land Use Right PrepaidForLandUseRight	15948501	usd
CY2023Q4	mhua	Prepaid For Property PrepaidForProperty	11267764	usd
CY2022Q4	mhua	Prepaid For Property PrepaidForProperty	12323842	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	25480370	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	28761901	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	11267764	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	12333122	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14212606	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16428779	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	10000000	cny
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	1420000	usd
CY2020Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.035	pure
CY2023Q4	us-gaap	Prepaid Interest PrepaidInterest	2500000	cny
CY2023Q4	us-gaap	Prepaid Interest PrepaidInterest	350000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	526522	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	177474	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2376	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	343795	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1048211	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	560119	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	40116	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	40650	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1617225	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1122038	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12691359	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12535348	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3860391	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3777301	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8830968	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8758047	usd
CY2023	us-gaap	Depreciation Depreciation	408233	usd
CY2022	us-gaap	Depreciation Depreciation	541265	usd
CY2021	us-gaap	Depreciation Depreciation	595522	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4381532	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	913097	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	465615	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	415497	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3915917	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	497600	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62149	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22196	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26951	usd
CY2023	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	3400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	85526	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	85526	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	84722	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	84454	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	84454	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3491235	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3915917	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	4832	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	290	usd
CY2023Q4	mhua	Short Term Borrowings1 ShortTermBorrowings1	52000000	cny
CY2023Q4	mhua	Short Term Borrowings1 ShortTermBorrowings1	7324047	usd
CY2022Q4	mhua	Short Term Borrowings1 ShortTermBorrowings1	42000000	cny
CY2022Q4	mhua	Short Term Borrowings1 ShortTermBorrowings1	6089428	usd
CY2023Q4	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	3586024	usd
CY2022Q4	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	2873795	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	5000000	cny
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	724932	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5000000	cny
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	3468	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	676	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7087	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2495	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4592	usd
CY2023Q4	mhua	Total Operating Lease Liabilities TotalOperatingLeaseLiabilities	7087	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0365	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2704	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2704	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2028	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	350	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7086	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	353887	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	380926	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	672245	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	690824	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	55999	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	59526	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1082131	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1131276	usd
CY2017Q4	mhua	Assessable Profits AssessableProfits	2000000	hkd
CY2017Q4	mhua	Lower Tax Percentage LowerTaxPercentage	0.0825	pure
CY2017Q4	mhua	Remaining Taxable Income Percentage RemainingTaxableIncomePercentage	0.165	pure
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3828207	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4713543	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5278462	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-370474	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3457733	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4713543	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5278462	usd
CY2023	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	15048773	usd
CY2022	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	18129648	usd
CY2021	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	26228041	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	3678233	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23940000	shares
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	3758113	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	5605035	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	16675	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	37169	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-13086	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	451154	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1660869	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	226222	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	688329	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	742608	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	539709	usd
CY2023	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	3457733	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	4713543	usd
CY2021	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	5278462	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	1	pure
CY2023Q4	mhua	Enterprise Income Tax Percentage EnterpriseIncomeTaxPercentage	0.25	pure
CY2016Q4	mhua	Preferential Tax Percentage PreferentialTaxPercentage	0.15	pure
CY2023Q4	mhua	Preferential Tax Percentage PreferentialTaxPercentage	0.15	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.10	pure
CY2023Q4	us-gaap	Capital Leases Of Lessor Contingent Rentals Basis Spread On Variable Rate CapitalLeasesOfLessorContingentRentalsBasisSpreadOnVariableRate	0.50	pure
CY2023Q4	us-gaap	Net Regulatory Assets NetRegulatoryAssets	15985627	usd
CY2022Q4	us-gaap	Net Regulatory Assets NetRegulatoryAssets	15665860	usd
CY2023Q4	us-gaap	Securities Loaned SecuritiesLoaned	21127	cny
CY2023Q1	us-gaap	Deposits Deposits	9200000	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	4507106	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	32000000	cny
CY2023	us-gaap	Repayments Of Longterm Loans From Vendors RepaymentsOfLongtermLoansFromVendors	3380329	usd
CY2023	us-gaap	Repayments Of Longterm Loans From Vendors RepaymentsOfLongtermLoansFromVendors	24000000	cny
CY2023	us-gaap	Securities Purchased Under Agreements To Resell Setoff Rights Description SecuritiesPurchasedUnderAgreementsToResellSetoffRightsDescription	On December 27, 2023, the Company entered into a securities purchase agreement (the “SPA”) with certain institutional investors (the “Investors”), pursuant to which the Company agreed to issue, from time to time, up to $50,500,0000 in the Company’s securities (the “Offering”), consisting of convertible notes, issuable at a 7.0% original issue discount (the “Notes”), and accompanying ordinary share purchase warrants (the “Warrants”) with five-year terms and exercisable for a number of the Company’s ordinary shares, par value $0.0005 per share (the “Ordinary Shares”), equal to 50% of the number obtained from dividing each Note’s principal amount by the applicable VWAP (as defined in the SPA), subject to adjustment pursuant and a 4.99% beneficial ownership limitation. Pursuant to the SPA, the Company agreed to issue to the Investors at the initial closing of the Offering (the “First Closing”) $6,000,000 in Notes, convertible at the lower of (i) $2.738 per share (or 110% of the VWAP of the Ordinary Shares on December 27, 2023) or (ii) a price per share equal to 95% of the lowest VWAP of the Ordinary Shares during the seven (7)-trading day period immediately preceding the applicable conversion date, subject to certain adjustments and a 4.99% beneficial ownership limitation, and Warrants exercisable for up to an aggregate of 1,205,255 ordinary shares, at an exercise price of $2.9869 per share (or 120% of the VWAP of the Ordinary Shares on December 27, 2023).
CY2023	mhua	Gross Proceeds GrossProceeds	5580000	usd
CY2023	mhua	Net Proceeds NetProceeds	4800000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20000000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23411068	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther		usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther		usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized After Tax ForeignCurrencyTransactionGainLossRealizedAfterTax		usd
CY2022	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal		usd
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal		usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2022	us-gaap	Increase Decrease Due From Other Related Parties IncreaseDecreaseDueFromOtherRelatedParties		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2021	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2022	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments		usd
CY2021	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments		usd
CY2022	mhua	Collection Of Longterm Deposits For Buildings CollectionOfLongtermDepositsForBuildings		usd
CY2021	mhua	Collection Of Longterm Deposits For Buildings CollectionOfLongtermDepositsForBuildings		usd
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
CY2021	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2021	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023	mhua	Shareholder Contribution Through Deferred Cost ShareholderContributionThroughDeferredCost		usd
CY2021	mhua	Shareholder Contribution Through Deferred Cost ShareholderContributionThroughDeferredCost		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Loss Foreign Currency Translation FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes		usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense		usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense		usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001835615

Files In Submission

Name	View Source	Status
0001213900-24-035784-index-headers.html	Edgar Link	pending
0001213900-24-035784-index.html	Edgar Link	pending
0001213900-24-035784.txt	Edgar Link	pending
0001213900-24-035784-xbrl.zip	Edgar Link	pending
ea0203873-20f_meihua.htm	Edgar Link	pending
ea020387301ex12-1_meihua.htm	Edgar Link	pending
ea020387301ex12-2_meihua.htm	Edgar Link	pending
ea020387301ex13-1_meihua.htm	Edgar Link	pending
ea020387301ex13-2_meihua.htm	Edgar Link	pending
ea020387301ex23-1_meihua.htm	Edgar Link	pending
ea020387301ex8-1_meihua.htm	Edgar Link	pending
ea020387301ex97-1_meihua.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0203873-20f_meihua_htm.xml	Edgar Link	completed
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
image_020.jpg	Edgar Link	pending
image_021.jpg	Edgar Link	pending
image_022.jpg	Edgar Link	pending
image_023.jpg	Edgar Link	pending
image_024.jpg	Edgar Link	pending
image_025.jpg	Edgar Link	pending
image_026.jpg	Edgar Link	pending
image_027.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mhua-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
mhua-20231231_def.xml	Edgar Link	unprocessable
mhua-20231231_lab.xml	Edgar Link	unprocessable
mhua-20231231_pre.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mhua-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MHUA
Meihua International Medical Technologies Co., Ltd. Stock $mhua

2023 Q4 Form 20-F Financial Statement

#000121390024035784 Filed on April 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MHUA Meihua International Medical Technologies Co., Ltd. Stock $mhua

2023 Q4 Form 20-F Financial Statement

#000121390024035784 Filed on April 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MHUA
Meihua International Medical Technologies Co., Ltd. Stock $mhua